Magnetic Technique for Sentinel Lymph Node Biopsy in Melanoma: The MELAMAG Trial
Authors:
- MELAMAG Multicentre Trialists GroupMGMELAMAG Multicentre Trialists Group
- Marc MoncrieffMMMarc Moncrieff
- Jenny L. C. GehJGJenny L. C. Geh
- 19 February 2016
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 23 (6) , 2070-2078
Abstract
Sentinel lymph node biopsy (SLNB) in melanoma is currently performed using the standard dual technique (radioisotope and blue dye). The magnetic techniqueKeywords
Funding Information
- Technology Strategy Board (130993)
This publication has 19 references indexed in Scilit:
- Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic reviewThe Lancet Oncology, 2014
- The Central-European SentiMag study: Sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotopeThe Breast, 2014
- Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in MelanomaNew England Journal of Medicine, 2014
- Sentinel Node Biopsy Using a Magnetic Tracer Versus Standard Technique: The SentiMAG Multicentre TrialAnnals of Surgical Oncology, 2013
- Preclinical studies of the role of iron oxide magnetic nanoparticles for nonpalpable lesion localization in breast cancerJournal of Surgical Research, 2013
- Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice GuidelineJournal of Clinical Oncology, 2012
- Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Melanoma: A Meta-AnalysisJournal of Clinical Oncology, 2011
- Increased post‐operative complications with methylene blue versus lymphazurin in sentinel lymph node biopsies for skin cancersJournal of Surgical Oncology, 2010
- Adverse reactions to patent blue V dye – The NEW START and ALMANAC experienceEuropean Journal of Surgical Oncology, 2010
- Sentinel Node Biopsy for Early-Stage MelanomaAnnals of Surgery, 2005